News
Important Only
Capital Southwest Corp expected to post earnings of 61 cents a share - Earnings Preview
Capital Southwest Corp CSWC.OQ CSWC.O is expected to show a rise in quarterly revenue when it reports results on May 14 for the period ending March 31 2025The Dallas Texas-based company is expected to report a 13.5% increase in revenue to $52.71 million from $46.43 million a year ago, according to...Reuters
Mon, May 12
Cadence Design Systems On May 8, Approved Repurchase Of Up To An Additional $1.5 Billion Of Co’S Common Stock Under Existing Share Repurchase Program
May 12 (Reuters) - Cadence Design Systems Inc CDNS.O:CADENCE DESIGN SYSTEMS: ON MAY 8, APPROVED REPURCHASE OF UP TO AN ADDITIONAL $1.5 BILLION OF CO’S COMMON STOCK UNDER EXISTING SHARE REPURCHASE PROGRAMReuters
Mon, May 12
Repay Holdings Board Of Directors Authorizes Increase To Share Repurchase Program, Up To $75 Million
May 12 (Reuters) - Repay Holdings Corp RPAY.O:REPAY BOARD OF DIRECTORS AUTHORIZES INCREASE TO SHARE REPURCHASE PROGRAM, UP TO $75 MILLIONREPAY BOARD OF DIRECTORS AUTHORIZES INCREASE TO SHARE REPURCHASE PROGRAM, UP TO $75 MILLIONReuters
Mon, May 12
Mobile Infrastructure Reports First Quarter 2025 Financial Results
May 12 (Reuters) - Mobile Infrastructure Corp BEEP.A:MOBILE INFRASTRUCTURE REPORTS FIRST QUARTER 2025 FINANCIAL RESULTSMOBILE INFRASTRUCTURE CORP - REAFFIRMS FULL YEAR GUIDANCEMOBILE INFRASTRUCTURE CORP - QTRLY TOTAL REVENUE $8.2 MILLION; ADJUSTED EBITDA $2.7 MILLIONReuters
Mon, May 12
Atara Biotherapeutics To Reduce Workforce By 30%
May 12 (Reuters) - Atara Biotherapeutics Inc ATRA.O:ATARA BIOTHERAPEUTICS INC - TO REDUCE WORKFORCE BY 30% - SEC FILINGATARA BIOTHERAPEUTICS INC - WORKFORCE REDUCTION EXPECTED TO COMPLETE BY AUGUST 2025 - SEC FILINGATARA BIOTHERAPEUTICS INC - TO INCUR $1.4 MILLION IN SEVERANCE COSTS - SEC FILINGReuters
Mon, May 12
Oncolytics Biotech Inc expected to post a loss of 10 cents a share - Earnings Preview
Oncolytics Biotech Inc ONC.TO is expected to show no change in quarterly revenue when it reports results on May 14 for the period ending March 31 2025LSEG's mean analyst estimate for Oncolytics Biotech Inc is for a loss of 10 cents per share. The current average analyst rating on the shares i...Reuters
Mon, May 12
Ascent Industries Co. Q1 EPS USD -0.1
May 12 (Reuters) - Ascent Industries Co ACNT.O:ASCENT INDUSTRIES CO. Q1 EPS USD -0.1ASCENT INDUSTRIES CO. Q1 ADJUSTED EBITDA USD 800 THOUSANDASCENT INDUSTRIES CO. Q1 NET INCOME USD -1 MILLIONASCENT INDUSTRIES CO. Q1 GROSS MARGIN 19.4%ASCENT INDUSTRIES CO. Q1 SALES USD 24.7 MILLIONASCENT INDUSTRIES C...Reuters
Mon, May 12
Berkshire Hathaway sold 1,145,938 DaVita shares pursuant to repurchase agreement, still owns 34 million
May 12 (Reuters) - Berkshire hathaway sold 1,145,938 davita shares for an average $147.11 each on may 8 pursuant to share repurchase agreement, owned 34 million davita shares following the sale, sec filing showsReuters
Mon, May 12
Shimmick Corp expected to post a loss of 25 cents a share - Earnings Preview
Shimmick Corp SHIM.OQ SHIM.O is expected to show a fall in quarterly revenue when it reports results on May 14 for the period ending March 31 2025The Irvine California-based company is expected to report a 21.4% decrease in revenue to $94.35 million from $120.04 million a year ago, according to th...Reuters
Mon, May 12
Regenxbio Q1 Net Income USD 6.083 Million
May 12 (Reuters) - Regenxbio Inc RGNX.O:REGENXBIO Q1 NET INCOME USD 6.083 MILLIONREGENXBIO Q1 OPERATING EXPENSES USD 76.885 MILLIONREGENXBIO Q1 LICENSE & ROYALTY REVENUE USD 87.049 MILLIONREGENXBIO INC: EXPECTS BALANCE OF $272.7 MILLION AS OF MARCH 31, 2025 TO FUND ITS OPERATIONS INTO H2 2026Reuters
Mon, May 12
Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview
Clearside Biomedical Inc CLSD.OQ CLSD.O is expected to show a fall in quarterly revenue when it reports results on May 14 for the period ending March 31 2025The Alpharetta Georgia-based company is expected to report a 26.1% decrease in revenue to $170 thousand from $230 thousand a year ago, accord...Reuters
Mon, May 12
Xtant Medical Reports First Quarter 2025 Financial Results
May 12 (Reuters) - Xtant Medical Holdings Inc XTNT.A:XTANT MEDICAL Q1 NET INCOME USD 1.3 MILLIONXTANT MEDICAL Q1 ADJUSTED EBITDA USD 3 MILLIONXTANT MEDICAL Q1 GROSS MARGIN 61.5%XTANT MEDICAL Q1 REVENUE USD 32.9 MILLIONXTANT MEDICAL Q1 OPERATING EXPENSES USD 19.2 MILLIONXTANT MEDICAL OUTLOOK FY REVEN...Reuters
Mon, May 12
Fed survey finds general ease in first-quarter credit demand
Fed report finds lighter first-quarter credit demandFed lending officer report flags tighter standards amid uncertain outlookCredit officers tightened standards for some lending typesBy Michael S. Derby and Ann Saphir May 12 (Reuters) - Top U.S. bank lending officers reported weaker demand from b...Reuters
Mon, May 12
